Trademark: 88491673
Status Date
Monday, January 24, 2022
Filing Date
Thursday, June 27, 2019
Published for Opposition
Tuesday, April 28, 2020
Abandoned Date
Monday, January 24, 2022
5 Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
Jan 24, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 24, 2022
Abandonment - No Use Statement Filed
May 26, 2021
Notice Of Approval Of Extension Request E-Mailed
May 24, 2021
Sou Extension 2 Granted
May 24, 2021
Sou Extension 2 Filed
May 24, 2021
Teas Extension Received
Dec 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2020
Sou Extension 1 Granted
Dec 14, 2020
Sou Extension 1 Filed
Dec 14, 2020
Teas Extension Received
Jun 23, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 28, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 28, 2020
Published For Opposition
Apr 8, 2020
Notification Of Notice Of Publication E-Mailed
Mar 24, 2020
Approved For Pub - Principal Register
Mar 19, 2020
Examiner's Amendment Entered
Mar 19, 2020
Notification Of Examiners Amendment E-Mailed
Mar 19, 2020
Examiners Amendment E-Mailed
Mar 19, 2020
Examiners Amendment -Written
Sep 19, 2019
Notification Of Non-Final Action E-Mailed
Sep 19, 2019
Non-Final Action E-Mailed
Sep 19, 2019
Non-Final Action Written
Sep 18, 2019
Assigned To Examiner
Aug 13, 2019
Preliminary/Voluntary Amendment - Entered
Aug 8, 2019
Assigned To Lie
Aug 1, 2019
Teas Voluntary Amendment Received
Jul 8, 2019
New Application Office Supplied Data Entered In Tram
Jul 1, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
